Literature DB >> 4296283

Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.

R M Chanock, W Ludwig, R J Heubner, T R Cate, L W Chu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4296283

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

1.  Comparison of WI-38, MRC-5, and IMR-90 cell strains for isolation of viruses from clinical specimens.

Authors:  H M Friedman; C Koropchak
Journal:  J Clin Microbiol       Date:  1978-04       Impact factor: 5.948

2.  Clinical aspects of protective immunity of the respiratory tract.

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1975-12       Impact factor: 9.139

Review 3.  Viral vector-based gene transfer for treatment of chronic pain.

Authors:  Shuanglin Hao; Marina Mata; David J Fink
Journal:  Int Anesthesiol Clin       Date:  2007

Review 4.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Pathology of exfoliated oropharyngeal epithelial cells infected with wild-type adenovirus.

Authors:  D P McCormick; Q Galapon; C Berling
Journal:  Appl Microbiol       Date:  1972-09

6.  Transforming region of group A, B, and C adenoviruses: DNA homology studies with twenty-nine human adenovirus serotypes.

Authors:  J K Mackey; W S Wold; P Rigden; M Green
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

7.  Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.

Authors:  J van der Veen; M F Abarbanel; K G Oei
Journal:  J Hyg (Lond)       Date:  1968-12

8.  Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults.

Authors:  Daniel A Blasiole; David Metzgar; Luke T Daum; Margaret A K Ryan; Jianguo Wu; Christopher Wills; Charles T Le; Nikki E Freed; Christian J Hansen; Gregory C Gray; Kevin L Russell
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.

Authors:  Zachary C Hartman; Daniel M Appledorn; Delila Serra; Oliver Glass; Todd B Mendelson; Timothy M Clay; Andrea Amalfitano
Journal:  Virology       Date:  2008-02-15       Impact factor: 3.616

Review 10.  Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Authors:  L Jean Patterson; Marjorie Robert-Guroff
Journal:  Expert Opin Biol Ther       Date:  2008-09       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.